Advanced Oncotherapy PLC (LON:AVO) crossed below its 50 day moving average during trading on Monday following a weaker than expected earnings announcement. The stock has a 50 day moving average of $26.68 and traded as low as $24.30. Advanced Oncotherapy shares last traded at $24.90, with a volume of 31,879 shares traded.
The company reported GBX (9.83) (($0.12)) EPS for the quarter, missing the consensus estimate of GBX (8.90) (($0.11)) by GBX (0.93) (($0.01)).
The company has a market capitalization of $79.66 million and a P/E ratio of -1.86. The stock has a fifty day simple moving average of GBX 26.61 and a 200-day simple moving average of GBX 32.04. The company has a quick ratio of 0.79, a current ratio of 2.16 and a debt-to-equity ratio of 55.71.
About Advanced Oncotherapy (LON:AVO)
Advanced Oncotherapy PLC, together with its subsidiaries, focuses on providing radiotherapy systems for the treatment of cancer. The company operates through two segments, Proton Therapy and Healthcare Related Properties. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer.
Further Reading: Why do companies pay special dividends?
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.